BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 38169949)

  • 1. Microbial metabolites are involved in tumorigenesis and development by regulating immune responses.
    Liu J; Tian R; Sun C; Guo Y; Dong L; Li Y; Song X
    Front Immunol; 2023; 14():1290414. PubMed ID: 38169949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial Metabolite Dysbiosis and Colorectal Cancer.
    Niekamp P; Kim CH
    Gut Liver; 2023 Mar; 17(2):190-203. PubMed ID: 36632785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet as a modifiable factor in tumorigenesis: Focus on microbiome-derived bile acid metabolites and short-chain fatty acids.
    Ahmad F; Saha P; Singh V; Wahid M; Mandal RK; Nath Mishra B; Fagoonee S; Haque S
    Food Chem; 2023 Jun; 410():135320. PubMed ID: 36610090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microbial metabolites in endocrine tumorigenesis: From the mechanistic insights to potential therapeutic biomarkers.
    Zhang Y; Tang N; Zhou H; Zhu Y
    Biomed Pharmacother; 2024 Mar; 172():116218. PubMed ID: 38308969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial metabolites, short-chain fatty acids, restrain tissue bacterial load, chronic inflammation, and associated cancer in the colon of mice.
    Kim M; Friesen L; Park J; Kim HM; Kim CH
    Eur J Immunol; 2018 Jul; 48(7):1235-1247. PubMed ID: 29644622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
    Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
    Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial metabolites in colorectal tumorigenesis and cancer therapy.
    Liu Y; Lau HC; Yu J
    Gut Microbes; 2023; 15(1):2203968. PubMed ID: 37095682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Gastrointestinal Immunity by Metabolites.
    Gu BH; Kim M; Yun CH
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33430497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of short-chain fatty acids in the immune system.
    Liu XF; Shao JH; Liao YT; Wang LN; Jia Y; Dong PJ; Liu ZZ; He DD; Li C; Zhang X
    Front Immunol; 2023; 14():1186892. PubMed ID: 37215145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of key gut microbial metabolites in the development and treatment of cancer.
    Jaye K; Li CG; Chang D; Bhuyan DJ
    Gut Microbes; 2022; 14(1):2038865. PubMed ID: 35220885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.
    Gao J; Xu K; Liu H; Liu G; Bai M; Peng C; Li T; Yin Y
    Front Cell Infect Microbiol; 2018; 8():13. PubMed ID: 29468141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome-Metabolomics Analysis of the Impacts of
    Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
    Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective.
    Fu Y; Lyu J; Wang S
    Front Immunol; 2023; 14():1277102. PubMed ID: 37876938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of short-chain fatty acids in immunity, inflammation and metabolism.
    Yao Y; Cai X; Fei W; Ye Y; Zhao M; Zheng C
    Crit Rev Food Sci Nutr; 2022; 62(1):1-12. PubMed ID: 33261516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Microbiota-Derived Metabolites in Colorectal Cancer.
    Duizer C; de Zoete MR
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial Metabolites Determine Host Health and the Status of Some Diseases.
    Sittipo P; Shim JW; Lee YK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications.
    Peng Y; Nie Y; Yu J; Wong CC
    Metabolites; 2021 Mar; 11(3):. PubMed ID: 33802045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells.
    Calvo-Barreiro L; Zhang L; Abdel-Rahman SA; Naik SP; Gabr M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of gut microbiota in the etiology of autoimmune hepatitis: a narrative review.
    Sun C; Zhu D; Zhu Q; He Z; Lou Y; Chen D
    Front Cell Infect Microbiol; 2024; 14():1337223. PubMed ID: 38404291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.